Yüklüyor......
Bleomycin‐induced pulmonary toxicity and treatment with infliximab: A case report
Given the current understanding of bleomycin‐induced pneumonitis (BIP), the use of tumor necrosis factor alpha (TNF‐α) inhibitors such as infliximab for late‐stage disease appears to be of limited benefit. Further research regarding prevention and management of advanced BIP is required.
Kaydedildi:
| Yayımlandı: | Clin Case Rep |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6186889/ https://ncbi.nlm.nih.gov/pubmed/30349718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1790 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|